Pharmaceutical Intellectual Property and Competition
In-Depth: Pharmaceutical Intellectual Property and Competition (formerly The Pharmaceutical Intellectual Property and Competition Law Review) provides a practical overview of pharmaceutical intellectual property issues, including patent linkage and exclusivities, and related competition concerns. With a focus on recent developments, it is a useful tool for managing global risks in this area – analysing the key elements of the relevant legal and regulatory regimes across major jurisdictions worldwide.
Overview
Jurisdictions
- Australia Jones Day
- Brazil Pinheiro Neto Advogados
- China Haiwen & Partners
- France August Debouzy
- Germany Kather Augenstein Rechtsanwälte PartGmbB
- India LexOrbis
- Japan Nishimura & Asahi (Gaikokuho Kyodo Jigyo)
- South Korea Lee & Ko
- Spain Uría Menéndez
- Taiwan Lee Tsai & Partners
- United Kingdom Bird & Bird LLP
- USA Arnold & Porter